These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8517462)

  • 1. Noncompliance with guidelines for intravascular use of lower-osmolality contrast media.
    Damiani DR; Swanson DP; Hanwell LL
    Am J Hosp Pharm; 1993 Jun; 50(6):1204-6. PubMed ID: 8517462
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced use of lower-osmolality contrast media resulting from an order form and guidelines.
    Swanson DP; Damiani-Hieronim DR; Baron RL
    Am J Hosp Pharm; 1994 Dec; 51(23):2952-5. PubMed ID: 7879806
    [No Abstract]   [Full Text] [Related]  

  • 3. An institutional approach to developing guidelines for the use of low-osmolality contrast agents.
    Swanson DP
    Appl Radiol; 1988 May; 17(5):27-8. PubMed ID: 10287384
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prospective study of adverse reactions to contrast media administered intravenously--a comparison of low-osmolality and high-osmolality contrast media].
    Higashi S; Takizawa K; Suzuki S; Nagashima J; Tamura S; Ishikawa M; Obuchi M; Katayama M
    Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Nov; 48(11):1364-70. PubMed ID: 3237463
    [No Abstract]   [Full Text] [Related]  

  • 5. Safer contrast agents?
    Dawson P; Allison DJ
    Br J Hosp Med; 1989 Nov; 42(5):406-7. PubMed ID: 2597825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-versus high-osmolality contrast media for intravenous use: a health care luxury or necessity?
    Powe NR
    Radiology; 1992 Apr; 183(1):21-2. PubMed ID: 1549674
    [No Abstract]   [Full Text] [Related]  

  • 7. A case study of the decision in Denmark to restrict use of high-osmolar contrast media in intravascular radiographic procedures.
    Thomsen HS; Archer JW; Schiermer L; Radensky PW
    Acad Radiol; 1997 Jun; 4(6):446-50. PubMed ID: 9189203
    [No Abstract]   [Full Text] [Related]  

  • 8. [Are intravenous contrast media improving?].
    Virkkunen P
    Duodecim; 1985; 101(4):385-92. PubMed ID: 3979323
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of contrast media.
    Baerlocher MO; Asch M; Myers A
    CMAJ; 2010 Apr; 182(7):697. PubMed ID: 20231343
    [No Abstract]   [Full Text] [Related]  

  • 10. [Iodinated contrast media and nephropathy. Estimated creatinine clearance for better assessment of renal function and dosage].
    Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C
    Ugeskr Laeger; 2004 Jun; 166(26-31):2566-72. PubMed ID: 15285166
    [No Abstract]   [Full Text] [Related]  

  • 11. [Iodinated contrast media and nephropathy--new recommendations. Estimated creatine clearance for better assessment of renal function and dosage].
    Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C
    Lakartidningen; 2003 Mar; 100(10):840-3, 846-8. PubMed ID: 12680021
    [No Abstract]   [Full Text] [Related]  

  • 12. ESUR guidelines on contrast media.
    Thomsen HS; Morcos SK;
    Abdom Imaging; 2006; 31(2):131-40. PubMed ID: 16447092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metformin and intravascular contrast media. National guidelines 2001-03-16].
    Lakartidningen; 2001 Apr; 98(16):1935-6. PubMed ID: 11370412
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravascular contrast media.
    Hosp Pharm; 1991 Mar; 26(3):275-6, 278. PubMed ID: 10113525
    [No Abstract]   [Full Text] [Related]  

  • 15. The promise of low osmolar contrast media: new data in cardiac angiography.
    Radensky P
    J Cardiovasc Manag; 1993; 4(1):23-7. PubMed ID: 10126705
    [No Abstract]   [Full Text] [Related]  

  • 16. European Society of Urogenital Radiology (ESUR) guidelines on the safe use of iodinated contrast media.
    Thomsen HS
    Eur J Radiol; 2006 Dec; 60(3):307-13. PubMed ID: 16965884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The financial impact of Denmark's decision to restrict the use of high-osmolar contrast media in intravascular radiographic procedures.
    Thomsen HS; Archer JW; Schiermer L; Radensky PW
    Eur Radiol; 1998; 8(2):321-2. PubMed ID: 9477291
    [No Abstract]   [Full Text] [Related]  

  • 18. [Patient's consent for radiological studies including intravascular administration of contrast media].
    Sośniak M
    Pol Przegl Radiol Med Nukl; 1971; 35(6):661-7. PubMed ID: 5142193
    [No Abstract]   [Full Text] [Related]  

  • 19. [Safety of radiological examinations with intravascular administration of contrast media].
    Pol Przegl Radiol Med Nukl; 1971; 35(6):641-8. PubMed ID: 5142191
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative safety of high-osmolality and low-osmolality radiographic contrast agents.
    Lasser EC
    Invest Radiol; 1992 May; 27(5):397-9. PubMed ID: 1582825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.